4Tabi Z,Moutaftsi M,Borysiewicz LK.Human cytomegalovirus pp65 and immediate early antigen specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens[J].Immunol,2001,166(9):5695-5703.
5Koffron AJ,Mueller KH,Kaufman DB,et al.Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus[J].Scand J Infect Dis supple,1995,99:61-62.
6The TH,van den Berg AP,van Son WJ,et al.Monitoring for cytomegalovirus after organ transplantation:a clinical perspective[J].Transplant Proc,1993,25(5 Suppl 4):5-9.
7The TH,van den Berg AP,Harmsen MC,et al.The cytomegalovirus antigenemia assay:a plea for standardization[J].Scand J Infect Dis Suppl,1995,999:25-29.
5Libby P, Ridker PM, Maseri A. Inflammation and Atherosclerosis[J].Circulation, 2002,105:1135-1143.
6Vila N, Castillo J, Davalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke[J].Stroke,2000,31(10):2325-2329.
7Grnholdt ML. Ultrasound and lipoproteins as predictors of lipid-rich, rupture-prone plaques in the carotid artery[J].Arterioscler Thromb Vasc Biol,1999,19:2-13.
8Hennerici MG. The unstable plaque[J].Cerebrovasc Dis,2004,17(suppl 3):17-22.
9O'Rourke F, Dean N, Akhtar N, et al. Current and future concepts in stroke prevention[J].CMAJ,2004,170(7):1123-1134.
10Gastillo J. Deteriorating stroke: diagnostic criteria, predictors, mechanisms and treatment[J].Cerebrovasc Dis,1999,9(suppl 3):1-8.
